2.97
                                            
                                Überblick
                                Nachrichten
                                Preisverlauf
                                    Optionskette
                                Financials
                                    Warum fällt ESPR?
                                Forum
                                Prognose
                                    Aktiensplit
                        
                        Esperion Therapeutics Inc Aktie (ESPR) Neueste Nachrichten
Why analysts remain bullish on Esperion Therapeutics Inc. stockWeekly Loss Report & Real-Time Volume Analysis - newser.com
Can volume confirm reversal in Esperion Therapeutics Inc.July 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Should you wait for a breakout in Esperion Therapeutics Inc.Trade Risk Assessment & Smart Allocation Stock Tips - newser.com
Is Esperion Therapeutics Inc. stock reversal real or fake2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com
Multi asset correlation models including Esperion Therapeutics Inc.July 2025 Drop Watch & Growth Focused Stock Reports - newser.com
Will Esperion Therapeutics Inc. stock gain from lower inflationJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com
Esperion Therapeutics (ESPR) to Release Quarterly Earnings on Thursday - MarketBeat
Why Esperion Therapeutics Inc. stock is favored by top institutions2025 Analyst Calls & Smart Allocation Stock Reports - newser.com
Can Esperion Therapeutics Inc. stock deliver surprise earnings beat2025 Technical Patterns & Safe Capital Preservation Plans - newser.com
Why Esperion Therapeutics Inc. is moving todayLong Setup & Risk Controlled Swing Alerts - newser.com
Will Esperion Therapeutics Inc. (0ET) stock benefit from mergersEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Will earnings trigger a reversal in Esperion Therapeutics Inc.Weekly Trade Recap & Weekly Breakout Watchlists - newser.com
Why analysts raise outlook for Esperion Therapeutics Inc. (0ET) stockMarket Activity Report & Free Technical Confirmation Trade Alerts - newser.com
Relative strength of Esperion Therapeutics Inc. in sector analysisEarnings Growth Report & Risk Controlled Daily Plans - newser.com
Smart tools for monitoring Esperion Therapeutics Inc.’s price action2025 Market Trends & Technical Buy Zone Confirmation - newser.com
How to use Fibonacci retracement on Esperion Therapeutics Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - newser.com
Using AI based signals to follow Esperion Therapeutics Inc.Portfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com
How high can Esperion Therapeutics Inc. stock go2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com
Published on: 2025-10-30 01:22:55 - newser.com
Identifying reversal signals in Esperion Therapeutics Inc.Quarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Applying Elliott Wave Theory to Esperion Therapeutics Inc.Quarterly Market Review & Community Consensus Trade Signals - newser.com
Esperion Therapeutics (NASDAQ:ESPR) Trading 7.1% HigherTime to Buy? - MarketBeat
How to integrate Esperion Therapeutics Inc. into portfolio analysis toolsWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com
Published on: 2025-10-28 23:56:41 - newser.com
Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET. - The Manila Times
How Esperion Therapeutics Inc. stock benefits from global expansion2025 Technical Patterns & Fast Entry High Yield Tips - newser.com
Esperion (NASDAQ: ESPR) sets Nov. 11, 2 p.m. ET KOL webinar on statin intolerance - Stock Titan
Will Esperion Therapeutics Inc. stock return to pre crisis levelsWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com
Can Esperion Therapeutics Inc. stock reach $100 price targetPortfolio Risk Summary & Technical Pattern Alert System - newser.com
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App
                